author-photo

Ned Adams

Baylor University Medical Center

8

Papers

335

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Case Report: Marked Survival Advantage of Two Colorectal Cancer Patients with Liver Metastases Treated with Vigil and FOLFOX-6.

2021 Vaccine
Show All
- Source
- Cite
- Save
Citations (0)
Case Report: Immune-mediated Complete Response in a Patient With Recurrent Advanced Ewing Sarcoma (EWS) After Vigil Immunotherapy.

2017 Journal of Pediatric Hematology Oncology
Show All
- Source
- Cite
- Save
Citations (8)
Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

2016 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (52)
Tolerability, humoral immune response, and disease control in phase 1 patients receiving ONT-10, a MUC1 liposomal vaccine.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Phase I Trial of Topotecan in Combination with Gemcitabine in Refractory Solid Tumor Patients

2004 Cancer Investigation
Show All
- Source
- Cite
- Save
Citations (5)
Characterization of a Novel Prostate-Specific Antigen–Activated Peptide-Doxorubicin Conjugate in Patients With Prostate Cancer

2002 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (66)